May 27, 2015
Larry Hsu, PhD'81, has been honored with the 2015 Alumni Distinguished Lifetime Achievement Award.

Chung-Chiang (Larry) Hsu, PhD‘81, has been named the 2015 Alumni Distinguished Lifetime Achievement Award winner. Alumni Distinguished Lifetime Achievement Award honors alumni who have made significant lifetime contributions in their profession or to society through practice, research, education, or public service.

Dr. Larry Hsu is currently Chairman & CEO of Lifemax Laboratories, Inc., and general partner at Hercules Bio-Venture Partners, as well as Capital Ten II Fund. Dr. Hsu co-founded Impax Pharmaceuticals, Inc. in 1995. Impax is a drug-delivery technology-based pharmaceutical company headquartered in the San Francisco Bay Area. In December 1999, Impax Pharmaceutical, Inc. went public through a reverse acquisition of Global Pharmaceuticals and changed its name to Impax Laboratories, Inc. Dr. Hsu was the President of Impax Laboratories until October 2006 when he assumed the additional responsibility of Chief Executive Officer.

In the past 18 years, Impax Laboratories grew to a company with more than 1000 employees and a market capitalization of over $2.5 billion. Dr. Hsu retired from Impax in April 2014 and started a new R&D company, Lifemax Laboratories, to focus his efforts on new drug development. He has also teamed up with partners to start two venture funds to help other start-up businesses.

Dr. Hsu received his PhD in Pharmaceutics from the University of Michigan in 1981. He authored several papers and book chapters in the natural products and formulation areas and is the holder of several patents.